CTRI/2021/03/031981尚未招募未知
Prevention of post-stroke seizures with Levetiracetam in Intracranial Cerebral Venous Sinus Thrombosis (PROLEVIS-CVT): A Randomized Placebo-Controlled Trial - PROLEVIS-CVT
DHRICMR0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Primary Prevention Arm
- •1. Adult patients (age > 18 years) presenting with intracranial venous sinus thrombosis proven by CT/MRI brain and CT/MR Venography
- •2. Confirmation of diagnosis to randomisation within 14 days
- •3. No seizures at presentation
- •Secondary Prevention Arm
- •1. Adult patients (age > 18 years) presenting with intracranial venous sinus thrombosis proven by CT/MRI brain and CT/MR Venography
- •2. Confirmation of diagnosis to randomisation within 14 days
- •3. Early post stroke seizures ( < 14 days)
排除标准
- •Primary Prevention Arm
- •1.Previous history of epilepsy or treatment with an AED
- •2.Seizure or status epilepticus at onset of stroke or prior to recruitment
- •3.Known allergy to Levetiracetam
- •4.Pregnant women
- •5.Chronic renal failure
- •Secondary Prevention Arm
- •1.Previous history of epilepsy or treatment with an AED
- •2.Status epilepticus at onset of stroke or prior to recruitment
- •3.Known allergy to Levetiracetam
- •4.Pregnant women
- •5.Chronic renal failure
研究者
相似试验
尚未招募
3 期
Prophylactic antiseizure medication in post cardiac arrest childreCTRI/2024/05/067855All India Institute of Medical Sciences Raipur
进行中（未招募）
1 期
Prophylactic treatment of stroke patients with eslicarbazepine acetate to prevent the development of epilepsyEUCTR2018-002747-29-SEBial - Portela & Ca, S.A.220
进行中（未招募）
1 期
Prophylactic treatment of stroke patients with eslicarbazepine acetate to prevent the development of epilepsyEUCTR2018-002747-29-PTBial - Portela & Ca, S.A.220
进行中（未招募）
1 期
Prophylactic treatment of stroke patients with eslicarbazepine acetate to prevent the development of epilepsyEUCTR2018-002747-29-ESBial - Portela & Ca, S.A.220
进行中（未招募）
1 期
Prophylactic treatment of stroke patients with eslicarbazepine acetate to prevent the development of epilepsyAdult patients at high-risk to develop post-stroke epilepsyMedDRA version: 22.1Level: PTClassification code 10076982Term: Post stroke epilepsySystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002747-29-ITBIAL-Portela & Ca, S.A.220